Company / Current Liabilities per Share
Insight Molecular Diagnostics Inc. Current Liabilities per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.69
FY2025
5-year range
$0.13 / $1.21
FY2021-FY2025
Trend
-21.4%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Current Liabilities per Share has fluctuated over the past 6 years, ranging from $0.13 in FY2022 to $1.21 in FY2023.
Based on SEC 10-K filings.
0.69 in FY2025 with a 5-year CAGR of +34.4%.
Improved from $1.21 to $0.69 over the past 2 years.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- +74.0%
- 5-Year CAGR
- +34.4%
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, current liabilities per share decreased 21.4% year-over-year.
- Peak current liabilities per share was recorded in FY2023.
- Lowest current liabilities per share in the period was in FY2022.
Company context
Key Data Points
- Altman Z-Score -7.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.69 | -21.4% |
| FY2024 | $0.88 | -27.4% |
| FY2023 | $1.21 | +823.9% |
| FY2022 | $0.13 | -35.8% |
| FY2021 | $0.20 | +29.5% |
| FY2020 | $0.16 | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026